Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Rankning i aktier #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Aktiekurs
$0.0202
Senast synkroniserad: 2024-11-19
Marknadsvärde
$44.67K
Förändring (1 dag)
-0.49%
Förändring (1 år)
0.00%
Land
IL
Handel Notable Labs, Ltd. (NTBL)

Kategori

P/S-tal för Notable Labs, Ltd. (NTBL)
P/S-tal per August 2026 TTM: 7.72
Enligt Notable Labs, Ltd. senaste finansiella rapporter och aktiekurs är det aktuella P/S-talet (TTM) 7.72. I slutet av 2022 hade företaget ett P/S-tal på 1.16K.
Historik för P/S-tal för Notable Labs, Ltd. från 2015 till 2026
P/S-tal vid årets slut
År P/S-tal Ändra
2026 (TTM) 7.72 -41.88%
2023 13.29 -98.86%
2022 1.16K -93.42%
2021 17.67K 387.47%
2020 3.63K -4.00%
2019 3.78K 97.37%
2018 1.91K 289.61%
2017 491.09 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
P/S-tal för liknande företag eller konkurrenter
Företag P/S-tal Skillnad i P/S-tal Land
9.88 27.92%
US
10.30 33.38%
NL
- -
CH
- -
KR
4.98 -35.54%
BE